Researcher Profile

Researcher Profile

Diane Hershock, MD, PhD

Diane Hershock, MD, PhD

Associate Professor, Department of Medicine
Division of Hematology and Oncology
Scientific Program:Next-Generation Therapies
Disease Teams:
Head and Neck Cancer
Melanoma and Skin Cancer
dmh58@psu.edu

Research Interests

  • Radiotherapy
  • Therapeutics
  • Blood Platelets
  • Head and Neck Neoplasms
  • Neoplasms
  • Drug Therapy
  • Fibrinogen
  • Survival
  • Squamous Cell Carcinoma of Head and Neck
  • Organ Preservation
  • Radiation Oncology
  • Chymotrypsin

Clinical Trials

Exercise in All ChemoTherapy (EnACT)
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrent Disease in Cutaneous Squamous Cell Carcinoma
A Phase Ib/11 Study of Propranolol with fixed-dose Pembrolizumab in Patients with Unresectable Stage III and Stage IV Melanoma
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial

Recent Publications

2020

Lewcun, JA, Pameijer, C, Kass, R, Cream, L, Hershock, D, Brooks, AJ & Dodge, DG 2020, 'Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: Two case reports', International Journal of Surgery Case Reports, vol. 68, pp. 83-87. https://doi.org/10.1016/j.ijscr.2020.02.036

2016

Nijenhuis, CM, Hellriegel, E, Beijnen, JH, Hershock, D, Huitema, ADR, Lucas, L, Mergui-Roelvink, M, Munteanu, M, Rabinovich-Guilatt, L, Robertson, P, Rosing, H, Spiegelstein, O & Schellens, JHM 2016, 'Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors', Investigational New Drugs, vol. 34, no. 5, pp. 565-574. https://doi.org/10.1007/s10637-016-0360-9

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)